Kenvue Confident Of Convincing Federal Court Of Safety Of Acetaminophen Use During Pregnancy

Plaintiff in complaint filed in US District Court for Southern New York alleges FDA-required pregnancy label warning for acetaminophen available under OTC monograph isn’t adequate and causes a failure to warn about potential risks.

• Source: Shuuterstock

Acetaminophen is “one of the most studied medications in history,” including research guiding the US Food and Drug Administration’s decision for a pregnancy label warning, argue attorneys for Kenvue Inc. in litigation challenging the safety of its Tylenol products.

The plaintiff in the complaint against Kenvue subsidiary Johnson & Johnson Consumer Inc

More from Legal

More from Policy & Regulation